Advertisement
Screener

Edgemoor Investment Advisors, Inc. Historic Quarter Change: Foreign Stocks, Reduced

Edgemoor Investment Advisors, Inc. historic quarter change: Foreign Stocks, Reduced

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 23 quarters from 2013-06-30 to 2026-06-30, Edgemoor Investment Advisors, Inc. opened 10 positions, added to 26, reduced 35 and sold out of 9.

  • Q2 2026: Stock TSM; Country of operation —; Class SPONSORED ADS; Shares before 69,777.
  • Q2 2026: Stock NVS; Country of operation —; Class SPONSORED ADR; Shares before 108,581.
  • Q1 2026: Stock SHEL; Country of operation —; Class SPON ADS; Shares before 157,501.
  • Q4 2025: Stock NVS; Country of operation —; Class SPONSORED ADR; Shares before 109,040.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1313792), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-07); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-13); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-10); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-06); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-11); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-05); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-10); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-12); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-07); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-09); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-03); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-09); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-09); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-06); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-07-31); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-08); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-03); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-07); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-11); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-09); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-10); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-06). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2004-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2026TSM
TAIWAN SEMICONDUCTOR MANUFAC
SPONSORED ADS69,77769,451-326$23,581,363$33,168,034+$9,586,6712026-08-07
Q2 2026NVS
NOVARTIS AG
SPONSORED ADR108,58152,824-55,757$16,585,887$8,278,682-$8,307,2052026-08-07
Q1 2026SHEL
SHELL PLC
SPON ADS157,501156,690-811$11,573,202$14,572,206+$2,999,0042026-05-13
Q4 2025NVS
NOVARTIS AG
SPONSORED ADR109,040108,330-710$13,983,406$14,935,583+$952,1772026-02-10
Q4 2025SHEL
SHELL PLC
SPON ADS161,029157,501-3,528$11,518,432$11,573,202+$54,7702026-02-10
Q3 2025NVS
NOVARTIS AG
SPONSORED ADR110,739109,040-1,699$13,400,637$13,983,406+$582,7692025-11-06
Q2 2025NVS
NOVARTIS AG
SPONSORED ADR112,334110,739-1,595$12,523,096$13,400,637+$877,5412025-08-11
Q2 2025NVO
NOVO-NORDISK A S
ADR15,72615,190-536$1,092,013$1,048,414-$43,5992025-08-11
Q1 2025NVS
NOVARTIS AG
SPONSORED ADR119,683112,334-7,349$11,646,410$12,523,096+$876,6862025-05-05
Q4 2024NVS
NOVARTIS AG
SPONSORED ADR126,444119,683-6,761$14,543,655$11,646,410-$2,897,2452025-02-10
Q4 2024SHEL
SHELL PLC
SPON ADS157,789155,418-2,371$10,406,232$9,736,983-$669,2492025-02-10
Q3 2024NVS
NOVARTIS AG
SPONSORED ADR129,969126,444-3,525$13,836,561$14,543,655+$707,0942024-11-12
Q2 2024NVS
NOVARTIS AG
SPONSORED ADR133,877129,969-3,908$12,950,009$13,836,561+$886,5522024-08-07
Q1 2024NVS
NOVARTIS AG
SPONSORED ADR135,206133,877-1,329$13,651,841$12,950,009-$701,8322024-05-09
Q3 2016NVS
NOVARTIS A G
SPONSORED ADR215,899214,568-1,331$17,808,000$16,939,000-$869,0002016-11-10
Q3 2016ORANY
ORANGE
FranceSPONSORED ADR258,230250,930-7,300$4,240,000$3,909,000-$331,0002016-11-10
Q2 2016NVS
NOVARTIS A G
SPONSORED ADR220,489215,899-4,590$15,972,000$17,808,000+$1,836,0002016-08-03
Q2 2016ORANY
ORANGE
FranceSPONSORED ADR264,360258,230-6,130$4,595,000$4,240,000-$355,0002016-08-03
Q1 2016NVS
NOVARTIS A G
SPONSORED ADR226,330220,489-5,841$19,473,000$15,972,000-$3,501,0002016-05-09
Q1 2016ORANY
ORANGE
FranceSPONSORED ADR277,646264,360-13,286$4,617,000$4,595,000-$22,0002016-05-09
Q4 2015NVS
NOVARTIS A G
SPONSORED ADR229,134226,330-2,804$21,062,000$19,473,000-$1,589,0002016-02-09
Q4 2015SNY
SANOFI
SPONSORED ADR210,808206,748-4,060$10,007,000$8,818,000-$1,189,0002016-02-09
Q4 2015ORANY
ORANGE
FranceSPONSORED ADR283,266277,646-5,620$4,283,000$4,617,000+$334,0002016-02-09
Q2 2015NVS
NOVARTIS AG ADR
ADR235,988231,718-4,270$23,271,000$22,787,000-$484,0002015-07-31
Q2 2015ORANY
ORANGE SPONSORED ADR
FranceADR287,666286,266-1,400$4,606,000$4,397,000-$209,0002015-07-31
Q1 2015NVS
NOVARTIS AG ADR
ADR237,713235,988-1,725$22,039,000$23,271,000+$1,232,0002015-05-08
Q1 2015ORANY
ORANGE SPONSORED ADR
FranceADR290,266287,666-2,600$4,911,000$4,606,000-$305,0002015-05-08
Q3 2014NVS
NOVARTIS AG ADR
COM243,418240,029-3,389$22,033,000$22,581,000+$548,0002014-11-07
Q3 2014ORANY
ORANGE SPONSORED ADR
FranceCOM302,701294,501-8,200$4,783,000$4,341,000-$442,0002014-11-07
Q2 2014NVS
NOVARTIS AG ADR
COM252,505243,418-9,087$21,468,000$22,033,000+$565,0002014-08-11
Q2 2014ORANY
ORANGE SPONSORED ADR
FranceCOM307,281302,701-4,580$4,514,000$4,783,000+$269,0002014-08-11
Q1 2014ORANY
Orange ADR
FranceCOM311,281307,281-4,000$3,844,000$4,514,000+$670,0002014-05-09
Q4 2013NVS
Novartis AG ADR
COM252,842251,100-1,742$19,396,000$20,183,000+$787,0002014-02-10
Q4 2013ORANY
Orange ADR
FranceCOM316,331311,281-5,050$3,957,000$3,844,000-$113,0002014-02-10
Q3 2013NVS
Novartis AG ADR
COM254,993252,842-2,151$18,031,000$19,396,000+$1,365,0002013-11-06

Similar Firms

Firm NameCountry13F ValueHoldings
HARBOR INVESTMENT ADVISORY, LLCUnited States$1.271B1,233
RMR Wealth BuildersUnited States$1.270B277
Summit Financial Strategies, Inc.United States$1.269B170
COZAD ASSET MANAGEMENT INCUnited States$1.273B421
P/E Global LLCUnited States$1.269B7
PPSC Investment Service CorpJapan$1.268B8
Fort Baker Capital Management LPUnited States$1.274B121
Sovran Advisors, LLCUnited States$1.275B649
CGN Advisors LLCUnited States$1.266B317
Gemmer Asset Management LLCUnited States$1.265B172